Hot Products

Mogroside III
Catalog No: CFN92190

The human intestinal bacteria shows potent ability to transform Mogroside III to release secondary glycoside mogroside II(A1) and aglycone mogrol.

Mogroside III-A1
Catalog No: CFN92193

Mogroside III-A1 is a natural product from Siraitia grosvenorii Swingle.

Mogroside III-A2
Catalog No: CFN92946

Mogroside III-A2 exhibits inhibitory effects with IC50 values of 346-400 mol ratio/32 pmol TPA. and shows weak inhibitory effects on activation of (+/-)-(E)-methyl-2-[(E)-hydroxyimino]-5-nitro-6-methoxy-3-hexemide (NOR 1), a nitric oxide (NO) donor.

Mogroside IV
Catalog No: CFN90389

Mogrosides IV is a sweet minor cucurbitane glycoside, it exhibits maltase inhibitory effect. Mogroside IV, Mogroside V and combinations thereof act as a Toll -Like Receptor -4 agonist and immune stimulant that can be utilized for both therapeutic vaccine design in cancer and for other pathogenic agents; therapy with Mogroside IV, Mogroside V and combinations thereof are also presented to created immune clearance of a viral infection.

Mogroside IVa
Catalog No: CFN92188

Mogroside IVa is a natural product from Siraitia grosvenorii Swingle.

Mogroside IVe
Catalog No: CFN92189

Mogroside IVe can inhibit the proliferation of HT29 and Hep-2 cells in culture and in xenografted mice in a dose-dependent manner, which is accompanied by the upregulation of tumor suppressor p53, and downregulation of matrix metallopeptidase 9 (MMP-9) and phosphorylated extracellular signal-regulated kinases (ERK)1/2.

Mogroside V
Catalog No: CFN99937

Mogroside V is a widely used sweetener, has in vitro AMPK activating effect, it also has anti-inflammatory potential in murine macrophages and a murine ear edema model, and has the potential to protect against LPS-induced airway inflammation in a model of ALI.

Mogroside VI
Catalog No: CFN90436

Lo Han Kuo extract is a high intensive sweetening agent with desirable health benefits, such as prevention of dental caries through specific antibacterial properties, no-calorie levels related to obesity, and a low glycemic index to help manage blood sugar levels in diabetic patients;mogrosides have the antimicrobial activity and the insulin-stimulating activity, this includes mogroside I, II, III, IV, V, mogroside VI, 11-o-Mogroside V, and Siamenoside I, siraitiflavandiol, rhamnocitrin-3-O-rhamnoside, and kaempferitrin that are the functional groups in these antimicrobial and insulin secretion activities.

Mollugin
Catalog No: CFN98930

Mollugin is a JAK2 inhibitor and inhibits LPS-induced inflammatory responses by blocking the activation of the JAK-STAT pathway. Mollugin may be a novel therapeutic candidate for bone loss-associated disorders including osteoporosis, rheumatoid arthritis, and periodontitis. Mollugin has anticancer efficacy, can modulate the HER2, HO-1, Nrf2 , and NF- κB pathways.

Momordicine I
Catalog No: CFN92076

Momordicine I has anti-diabetic and antifeedant activities.